Inhibition of angiogenesis: common theme for cancer and atheromatosis?
Bamias
Aristotle
A
Dimopoulos
Meletios A
MA
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D050197:Atherosclerosis / Q000503:physiopathology*; D000068258:Bevacizumab; D023903:Coronary Restenosis / Q000517:prevention & control; D009369:Neoplasms / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D015607:Stents
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab